Log in to save to my catalogue

Pharmacokinetic Evaluation of Rifabutin in Combination with Lopinavir-Ritonavir in Patients with HIV...

Pharmacokinetic Evaluation of Rifabutin in Combination with Lopinavir-Ritonavir in Patients with HIV...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_754545004

Pharmacokinetic Evaluation of Rifabutin in Combination with Lopinavir-Ritonavir in Patients with HIV Infection and Active Tuberculosis

About this item

Full title

Pharmacokinetic Evaluation of Rifabutin in Combination with Lopinavir-Ritonavir in Patients with HIV Infection and Active Tuberculosis

Publisher

Oxford: The University of Chicago Press

Journal title

Clinical infectious diseases, 2009-11, Vol.49 (9), p.1305-1311

Language

English

Formats

Publication information

Publisher

Oxford: The University of Chicago Press

More information

Scope and Contents

Contents

Background.Human immunodeficiency virus (HIV)-associated tuberculosis is difficult to treat, given the propensity for drug interactions between the rifamycins and the antiretroviral drugs. We examined the pharmacokinetics of rifabutin before and after the addition of lopinavir-ritonavir. Methods.We analyzed 10 patients with HIV infection and active...

Alternative Titles

Full title

Pharmacokinetic Evaluation of Rifabutin in Combination with Lopinavir-Ritonavir in Patients with HIV Infection and Active Tuberculosis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_754545004

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_754545004

Other Identifiers

ISSN

1058-4838

E-ISSN

1537-6591

DOI

10.1086/606056

How to access this item